SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-136842
Filing Date
2021-04-28
Accepted
2021-04-28 16:06:26
Documents
90
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d26234d10q.htm   iXBRL 10-Q 2263823
2 EX-31.1 d26234dex311.htm EX-31.1 10334
3 EX-31.2 d26234dex312.htm EX-31.2 10319
4 EX-32 d26234dex32.htm EX-32 4308
  Complete submission text file 0001193125-21-136842.txt   10025661

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA teva-20210331.xsd EX-101.SCH 73318
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20210331_cal.xml EX-101.CAL 44304
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20210331_def.xml EX-101.DEF 501400
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20210331_lab.xml EX-101.LAB 510710
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20210331_pre.xml EX-101.PRE 535042
10 EXTRACTED XBRL INSTANCE DOCUMENT d26234d10q_htm.xml XML 1997533
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 21864235
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences